Artwork

Content provided by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari

53:16
 
Share
 

Manage episode 296887274 series 2547109
Content provided by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
  continue reading

372 episodes

Artwork
iconShare
 
Manage episode 296887274 series 2547109
Content provided by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
  continue reading

372 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide